600+ sources. One page. See who else covered it.
In this week’s edition of InnovationRx, we look at the potential impact of Trump’s executive order on vaccines, the healthcare dynamos on Forbes 50 Over 50, a Swiss startup focused on a rare bleeding disorder, and more.
We haven't written up this one. Forbes has the full story — the link below goes straight to it.
Children from disadvantaged backgrounds often start school with lower working memory scores. A large study tracking students through fifth grade reveals how mentally stimulating activities like…
Ultra-processed foods (UPFs) account for nearly 60% of adults' and 70% of children's energy intake in the United States. These industrially manufactured products—such as soft drinks, packaged cereals…
The study has been touted by Vermont Senator Bernie Sanders as proof of the benefits of a universal, single-payer healthcare system, but the research hasn't been peer-reviewed
Self-optimization is the next evolutionary step for bioprocessing purification systems and, although that step is near, it currently is hindered by missing integrations among its many parts and by…
An allogeneic CAR T-cell therapy company is planning a pivotal Phase III randomized-control trial, hoping their products can reach more patients and help those who can’t access autologous therapies.
Bioprocessing companies face pressure to cut emissions while maintaining production standards. CRB experts said better data collection, strategic planning, and emerging technologies are helping…